Humacyte Inc

Humacyte Inc

HUMA

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.13B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Humacyte IncHumacyte Inc-1.3--253%-2.1
$2.00

Target Price by Analysts

193.4% upsideHumacyte Target Price DetailsTarget Price
$-0.11

Current Fair Value

115.9% downside

Overvalued by 115.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.13 Billion
Enterprise Value$1.12 Billion
Dividend Yield$- (-)
Earnings per Share$-0.26
Beta2.47
Outstanding Shares234,182,284

Return

Return on Equity-253.43%ROE
Return on Assets-57.37%
Return on Invested Capital-77.99%

Valuation & Multiples

P/E Ratio-1.26P/E Ratio
PEG55.51PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue526.38
Enterprise Value to EBIT-11.62
Enterprise Value to Net Income-15
Total Debt to Enterprise0.06
Debt to Equity2.12Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 17, 2026
EPS Estimate
$-0.11
Average shareholder expectation
Revenue Estimate
$2.02 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 6, 2026
EPS Estimate
$-0.09
Average shareholder expectation
Revenue Estimate
$1.02 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5083 8.82%
Total Calls1,663,900 31.74%
Total Puts845,800 59.40%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %37.72% 7.88%
Total Invested$58.22M 62.23%
Investors Holding172 6.00%

ESG Score

No data

About Alpha Healthcare Acquisition Corp.

CEO: Mr. Rajiv Sarman Shukla

Alpha Healthcare Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in New York, New York.